National Breast and Cervical Cancer Early Detection Program (NBCCEDP) Monitoring Activities

ICR 202009-0920-022

OMB: 0920-1046

Federal Form Document

Forms and Documents
Document
Name
Status
Form and Instruction
Modified
Form and Instruction
Modified
Form and Instruction
Modified
Justification for No Material/Nonsubstantive Change
2020-09-28
Supplementary Document
2018-10-24
Supplementary Document
2018-10-24
Supplementary Document
2018-10-24
Supplementary Document
2018-10-24
Supplementary Document
2018-10-24
Supplementary Document
2018-10-24
Supplementary Document
2018-10-24
Supplementary Document
2018-10-24
Supplementary Document
2018-10-24
Supplementary Document
2018-10-24
Supplementary Document
2018-10-24
Supplementary Document
2018-10-24
Supplementary Document
2018-10-24
Supporting Statement B
2018-10-24
Supporting Statement A
2018-10-24
ICR Details
0920-1046 202009-0920-022
Active 201805-0920-008
HHS/CDC 14BA
National Breast and Cervical Cancer Early Detection Program (NBCCEDP) Monitoring Activities
No material or nonsubstantive change to a currently approved collection   No
Regular
Approved without change 10/09/2020
Retrieve Notice of Action (NOA) 09/28/2020
Previous terms continue: Any changes to the instruments need to be submitted for OMB approval (either as revisions or non-substantive changes requests, depending on the nature and extent of the changes) prior to use.
  Inventory as of this Action Requested Previously Approved
11/30/2021 11/30/2021 11/30/2021
910 0 910
764 0 683
38,976 0 38,976

The goal of this data collection is to systematically collect information about the implementation and outcomes of the National Breast and Cervical Cancer Early Detection Program (NBCCEDP), which funds 70 grantees. CDC will conduct an annual grantee survey and collect clinic-level information from grantees’ health system partners. The subpopulation for the grantee survey is the 70 NBCCEDP program directors/program managers. Clinic-level information, including breast and cervical screening rates, represents clients ages 50-74 for breast cancer screenings and 21-65 for cervical cancer screenings within partner health systems. This information collection will allow CDC to conduct routine monitoring, tailor technical assistance, support program planning, and assess program outcomes.

US Code: 42 USC 300k Name of Law: Breast and Cervical Cancer Mortality Prevention Act of 1990
   PL: Pub.L. 101 - 354 2 Name of Law: Breast and Cervical Cancer Prevention and Treatment Act of 2000
  
None

Not associated with rulemaking

  83 FR 3711 01/26/2018
83 FR 53877 10/25/2018
No

  Total Approved Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 910 910 0 0 0 0
Annual Time Burden (Hours) 764 683 0 81 0 0
Annual Cost Burden (Dollars) 38,976 38,976 0 0 0 0
Yes
Miscellaneous Actions
No
In 2017, CDC redesigned the NBCCEDP to have a stronger focus on grantees partnering with health system clinics to implement evidence-based interventions (EBIs). Consistent with these programmatic changes, CDC proposes redesigned information collection to include a revised grantee survey and 2 new clinic-level data collections. The number of respondents will increase from 67 to 70, and the estimated annualized burden will increase from 45 hours to 683 hours. In SEPT 2020 CDC proposed new questions to assess the impact of COVID-19 on NBCCEDP operations.

$507,284
Yes Part B of Supporting Statement
    No
    No
No
No
No
Yes
Renita Macaluso 770 488-6458 arp5@cdc.gov

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
09/28/2020


© 2024 OMB.report | Privacy Policy